361 related articles for article (PubMed ID: 27285996)
1. Electroconvulsive Therapy Added to Non-Clozapine Antipsychotic Medication for Treatment Resistant Schizophrenia: Meta-Analysis of Randomized Controlled Trials.
Zheng W; Cao XL; Ungvari GS; Xiang YQ; Guo T; Liu ZR; Wang YY; Forester BP; Seiner SJ; Xiang YT
PLoS One; 2016; 11(6):e0156510. PubMed ID: 27285996
[TBL] [Abstract][Full Text] [Related]
2. ECT augmentation of clozapine for clozapine-resistant schizophrenia: A meta-analysis of randomized controlled trials.
Wang G; Zheng W; Li XB; Wang SB; Cai DB; Yang XH; Ungvari GS; Xiang YT; Correll CU
J Psychiatr Res; 2018 Oct; 105():23-32. PubMed ID: 30144667
[TBL] [Abstract][Full Text] [Related]
3. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
Krzystanek M; Krupka-Matuszczyk I
Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of adjunctive topiramate for schizophrenia: a meta-analysis of randomized controlled trials.
Zheng W; Xiang YT; Xiang YQ; Li XB; Ungvari GS; Chiu HF; Correll CU
Acta Psychiatr Scand; 2016 Nov; 134(5):385-398. PubMed ID: 27585549
[TBL] [Abstract][Full Text] [Related]
5. Adjunctive Electroconvulsive Therapy for Schizophrenia: A Meta-analysis of Randomized Rater-Masked Controlled Trials [RETRACTED].
Zheng W; Xiang YT; Tang YL; Xiang YQ; Li XB; Cao XL; Guo T; Liu ZR; Chiu HF; Ungvari GS; de Leon J
J ECT; 2016 Aug; ():. PubMed ID: 27428477
[TBL] [Abstract][Full Text] [Related]
6. Clozapine Augmentation With Antiepileptic Drugs for Treatment-Resistant Schizophrenia: A Meta-Analysis of Randomized Controlled Trials.
Zheng W; Xiang YT; Yang XH; Xiang YQ; de Leon J
J Clin Psychiatry; 2017 May; 78(5):e498-e505. PubMed ID: 28355041
[TBL] [Abstract][Full Text] [Related]
7. Risperidone versus other atypical antipsychotic medication for schizophrenia.
Gilbody SM; Bagnall AM; Duggan L; Tuunainen A
Cochrane Database Syst Rev; 2000; (3):CD002306. PubMed ID: 10908551
[TBL] [Abstract][Full Text] [Related]
8. Is electroconvulsive therapy effective as augmentation in clozapine-resistant schizophrenia?
Kittsteiner Manubens L; Lobos Urbina D; Aceituno D
Medwave; 2016 Oct; 16(Suppl5):e6577. PubMed ID: 27813505
[TBL] [Abstract][Full Text] [Related]
9. Electroconvulsive Therapy Alone for Schizophrenia: A Meta-analysis of Randomized, Single-blind, Controlled Trials [RETRACTED].
Zheng W; Xiang YQ; Ungvari GS; Ng CH; Chiu HF; Liu ZR; Cao XL; Guo T; Wang HH; Seiner SJ; Xiang YT
J ECT; 2016 Aug; ():. PubMed ID: 27227402
[TBL] [Abstract][Full Text] [Related]
10. Clozapine versus typical neuroleptic medication for schizophrenia.
Wahlbeck K; Cheine M; Essali MA
Cochrane Database Syst Rev; 2000; (2):CD000059. PubMed ID: 10796289
[TBL] [Abstract][Full Text] [Related]
11. Randomized, double-blind, sham-controlled trial to evaluate the efficacy and tolerability of electroconvulsive therapy in patients with clozapine-resistant schizophrenia.
Melzer-Ribeiro DL; Napolitano IC; Leite SA; Alencar de Souza JA; Vizzotto ADB; Di Sarno ES; Fortes M; Gomes ML; de Oliveira GM; Avrichir BS; Talib LL; Correll CU; Elkis H
Schizophr Res; 2024 Jun; 268():252-260. PubMed ID: 38151432
[TBL] [Abstract][Full Text] [Related]
12. Augmentation of clozapine with electroconvulsive therapy in treatment resistant schizophrenia: A systematic review and meta-analysis.
Lally J; Tully J; Robertson D; Stubbs B; Gaughran F; MacCabe JH
Schizophr Res; 2016 Mar; 171(1-3):215-24. PubMed ID: 26827129
[TBL] [Abstract][Full Text] [Related]
13. Electroconvulsive Therapy for Agitation in Schizophrenia: Metaanalysis of Randomized Controlled Trials.
Gu X; Zheng W; Guo T; Ungvari GS; Chiu HFK; Cao X; D'Arcy C; Meng X; Ning Y; Xiang Y
Shanghai Arch Psychiatry; 2017 Feb; 29(1):1-14. PubMed ID: 28769540
[TBL] [Abstract][Full Text] [Related]
14. Continuation Electroconvulsive Therapy for Patients With Clozapine-Resistant Schizophrenia: A Pilot Study.
Braga RJ; John M; Schooler NR; Bailine SH; Malur C; Mendelowitz A; Petrides G
J ECT; 2019 Sep; 35(3):156-160. PubMed ID: 30973454
[TBL] [Abstract][Full Text] [Related]
15. Antipsychotic combinations vs monotherapy in schizophrenia: a meta-analysis of randomized controlled trials.
Correll CU; Rummel-Kluge C; Corves C; Kane JM; Leucht S
Schizophr Bull; 2009 Mar; 35(2):443-57. PubMed ID: 18417466
[TBL] [Abstract][Full Text] [Related]
16. Efficacy for Psychopathology and Body Weight and Safety of Topiramate-Antipsychotic Cotreatment in Patients With Schizophrenia Spectrum Disorders: Results From a Meta-Analysis of Randomized Controlled Trials.
Correll CU; Maayan L; Kane J; Hert MD; Cohen D
J Clin Psychiatry; 2016 Jun; 77(6):e746-56. PubMed ID: 27337425
[TBL] [Abstract][Full Text] [Related]
17. Quetiapine versus other atypical antipsychotics for schizophrenia.
Asmal L; Flegar SJ; Wang J; Rummel-Kluge C; Komossa K; Leucht S
Cochrane Database Syst Rev; 2013 Nov; (11):CD006625. PubMed ID: 24249315
[TBL] [Abstract][Full Text] [Related]
18. Amantadine for Antipsychotic-Related Weight Gain: Meta-Analysis of Randomized Placebo-Controlled Trials.
Zheng W; Wang S; Ungvari GS; Ng CH; Yang XH; Gu YH; Li M; Xiang YQ; Xiang YT
J Clin Psychopharmacol; 2017 Jun; 37(3):341-346. PubMed ID: 28383359
[TBL] [Abstract][Full Text] [Related]
19. Long-term clinical efficacy of maintenance electroconvulsive therapy in patients with treatment-resistant schizophrenia on clozapine.
Youn T; Jeong SH; Kim YS; Chung IW
Psychiatry Res; 2019 Mar; 273():759-766. PubMed ID: 31207863
[TBL] [Abstract][Full Text] [Related]
20. Augmentation of clozapine with ECT: a retrospective case analysis.
Lally J; Breese E; Osman M; Hua Sim C; Shetty H; Krivoy A; MacCabe JH
Acta Neuropsychiatr; 2021 Feb; 33(1):31-36. PubMed ID: 32967745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
